HVAX doubles HQ space and completes landmark oncology build in Nigeria

By Sophie Bullimore | Published: 27-Mar-2024

India-based pharmaceutical design and build expert HVAX Technologies has completed a landmark oncology centre in Nigeria alongside its Mumbai HQ expansion

HVAX Technologies has announced a major milestone for the company that has been in operation for over a decade.

The India-based company has officially doubled its office space Kanjurmarg, Mumbai.

"As a testament to our unwavering dedication, relentless efforts, and the incredible support of our team and partners, we are now proudly situated on two floors within the same dynamic building," the company stated on LinkedIn.

"This expansion symbolises not just our growth in physical space, but also our exponential growth as a company, fueled by innovation, passion, and a commitment to excellence," the company added.

HVAX Technologies is a design and build expert in pharmaceutical facilities.

New subsidiary

The company's LinkedIn profile states that it has over 200 employees at this time, and the company also launched a new business venture, ISOVAX Containment Technologies, in 2021.

ISOVAX Containment Technologies designs, manufactures and validates transportable, table top and standalone containment equipment for the pharmaceutical & biotech industry.

New product

In mid-2023, the company also unveiled its latest innovation, Nitroglox. The nitrogen-purging glove box adds to the company's pharmaceutical portifolio.

Recent project

Earlier in 2024, the company also successfully completed an oncology centre in Lagos, Nigeria, one of the very few cancer treatment centres with Cyclotron abilities.

HVAX used technologies from seamless epoxy flooring to advanced HVAC systems and customisable partition panels.

"Every detail reflects our commitment to perfection." the company stated.

You may also like